Fingerprint
Dive into the research topics of 'Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
S. Novello, G. V. Scagliotti, R. Rosell, M. A. Socinski, J. Brahmer, J. Atkins, C. Pallares, R. Burgess, L. Tye, P. Selaru, E. Wang, R. Chao, R. Govindan
Research output: Contribution to journal › Letter › peer-review